Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 1 |
2012 | 1 |
2014 | 1 |
2015 | 1 |
2016 | 1 |
2017 | 3 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.
Neurology. 2017 Jan 10;88(2):152-159. doi: 10.1212/WNL.0000000000003478. Epub 2016 Dec 2.
Neurology. 2017.
PMID: 27913695
Free PMC article.
Clinical Trial.
Analysis of Participant Withdrawal in Huntington Disease Clinical Trials.
Banno H, Andrzejewski KL, McDermott MP, Murphy A, Majumder M, de Blieck EA, Auinger P, Cudkowicz ME, Atassi N.
Banno H, et al.
J Huntingtons Dis. 2017;6(2):149-156. doi: 10.3233/JHD-170246.
J Huntingtons Dis. 2017.
PMID: 28671136
Free PMC article.
Item in Clipboard
Practice parameter update: evaluation and management of driving risk in dementia: report of the Quality Standards Subcommittee of the American Academy of Neurology.
Iverson DJ, Gronseth GS, Reger MA, Classen S, Dubinsky RM, Rizzo M; Quality Standards Subcomittee of the American Academy of Neurology.
Iverson DJ, et al.
Neurology. 2010 Apr 20;74(16):1316-24. doi: 10.1212/WNL.0b013e3181da3b0f. Epub 2010 Apr 12.
Neurology. 2010.
PMID: 20385882
Free PMC article.
Review.
Item in Clipboard
Oral repeated-dose toxicity studies of coenzyme Q10 in beagle dogs.
Yerramilli-Rao P, Beal MF, Watanabe D, Kieburtz K, Blieck EA, Kitano M, Hosoe K, Funahashi I, Cudkowicz ME.
Yerramilli-Rao P, et al.
Int J Toxicol. 2012 Jan-Feb;31(1):58-69. doi: 10.1177/1091581811425256. Epub 2012 Jan 20.
Int J Toxicol. 2012.
PMID: 22267890
Free PMC article.
Item in Clipboard
The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD study.
Sharp ME, Caccappolo E, Mejia-Santana H, Tang MX, Rosado L, Orbe Reilly M, Ruiz D, Louis ED, Comella C, Nance M, Bressman S, Scott WK, Tanner C, Waters C, Fahn S, Cote L, Ford B, Rezak M, Novak K, Friedman JH, Pfeiffer R, Payami H, Molho E, Factor SA, Nutt J, Serrano C, Arroyo M, Pauciulo MW, Nichols WC, Clark LN, Alcalay RN, Marder KS.
Sharp ME, et al.
Mov Disord. 2015 Feb;30(2):278-83. doi: 10.1002/mds.26065. Epub 2014 Nov 12.
Mov Disord. 2015.
PMID: 25393808
Free PMC article.
Item in Clipboard
Motor, cognitive, and functional declines contribute to a single progressive factor in early HD.
Schobel SA, Palermo G, Auinger P, Long JD, Ma S, Khwaja OS, Trundell D, Cudkowicz M, Hersch S, Sampaio C, Dorsey ER, Leavitt BR, Kieburtz KD, Sevigny JJ, Langbehn DR, Tabrizi SJ; TRACK-HD, COHORT, CARE-HD, and 2CARE Huntington Study Group Investigators.
Schobel SA, et al.
Neurology. 2017 Dec 12;89(24):2495-2502. doi: 10.1212/WNL.0000000000004743. Epub 2017 Nov 15.
Neurology. 2017.
PMID: 29142089
Free PMC article.
Item in Clipboard
Cite
Cite